Table 1.
The demographics of the subjects enrolled in the study.
| Group(Vaccine administered1) | Total(N/A2) | 30μg - (30μg HA) | 1.5μg +(1.5μg HA adjuvanted with 50μg Matrix M) | 7.5μg +(7.5μg HA adjuvanted with 50μg Matrix M) | 30μg +(30μg HA adjuvanted with 50μg Matrix M) |
|---|---|---|---|---|---|
| No. of subjects | 60 | 15 | 15 | 153 | 15 |
| Gender, M/F | 22/38 | 6/9 | 5/10 | 7/8 | 4/11 |
| Median age, years (Range) |
30 (20-49) |
30 (20-41) |
26 (21-44) |
28 (22-42) |
30 (25-49) |
| No. of subjects with previous vaccinations and/or infection4 | 25 | 6 | 8 | 4 | 7 |
1The vaccine was supplied as prefilled syringes of pre-formulated virosomal vaccine with Matrix M.
2Not applicable (N/A).
3One withdrawal after first dose vaccine in 7.5μg + group.
4Annual seasonal influenza vaccines during 2005/06-2008/09 seasons were included as previous vaccinations. Influenza infection during 2008/09 season was included as infection. In addition, three subjects received the H7N1 vaccine in a clinical trial in 2006, which was not included in the table.